Press Releases IXICO plc

Stocks

IXI

GB00BFXR4C20

Biotechnology & Medical Research

Delayed London S.E. Other stock markets 06:23:55 2026-06-15 EDT			5-day change	1st Jan Change
8.500 ^GBX	-1.73%		-1.73%	-27.66%

06-08	Ixico plc Announces Appointments on Scientific Advisory Board	CI
06-08	Ixico Has Enters into A Research Collaboration with the Paris Brain Institute	CI

Press Releases

12-17	IXICO : AGM Notice 2026	PU
12-09	IXICO : ANNUAL RESULTS PRESENTATION (2025 Final Results Presentation FINAL v2)	PU
12-04	AI-Driven Recruitment for Alzheimer’s Disease Clinical Trials: A Pilot Analysis on the A4 Study Dataset	PU
12-01	IXICO : strengthens Scientific Advisory Board with two prominent global Alzheimer’s Disease and vascular experts	PU
11-17	IXICO : Global Phase 3 Clinical Trial Contract Win	PU
11-03	IXICO : CAPITAL MARKETS DAY PRESENTATION (Capital Markets Day 30 October 2025 FINAL 1)	PU
25-10-16	IXICO : CEO Bram Goorden on strong 2025 performance, 2026 priorities	PU
25-10-16	IXICO : CEO on strong 2025 performance, 2026 priorities	PU
25-10-16	IXICO : Trading update for the year ended 30 September 2025	PU
25-08-12	IXICO : Global clinical trial contract wins in Alzheimer’s Disease and Friedreich’s Ataxia	PU
25-07-22	IXICO : Strategic Partnership between IXICO and the Global Alzheimer’s Platform Foundation (GAP)	PU
25-06-05	IXICO : assists first FDA clearance of new Alzheimer’s Disease blood based diagnostic biomarker	PU
25-05-20	IXICO : Interim results for six months ending 31 March 2025	PU
25-04-16	IXICO : Half year Trading update FY2025	PU
25-03-11	Comparison of two natural history studies as part of the HD-IH consortium: a use case for historical external control group matching in clinical trials	PU
25-02-12	IXICO : Huntington’s Disease consortium further validates IXICO’s AI imaging platform	PU
24-12-16	IXICO : Commercial agreement with PETNET Solutions Inc, a Siemens Healthineers Company	PU
24-12-10	IXICO : US Client Clinical Trial Contract Win	PU
24-09-05	Neuroimaging to Facilitate Clinical Trials in Huntington’s Disease: Current Opinion from the EHDN Imaging Working Group - IOS Press	PU
24-08-05	IXICO : Appointment of CEO - Bram Goorden	PU
24-05-23	IXICO : to support on Global Alzheimer's Platform Foundation's Bio-Hermes 2 trial	PU
23-07-12	IXICO : Huntington’s Disease Image Harmonization Consortium secures new member and funding to complete large-scale analysis of brain changes using IXIQ.Ai	PU
23-04-03	IXICO : Deep-learning methods for enrichment of Alzheimer’s Disease clinical trials using MRI and PET	PU
22-12-16	IXICO : AGM 2023 – Notice	PU
22-12-12	IXICO : Application of fully automatic Hippocampal sub-field segmentation volumes to standard resolution T1 MR Imaging in Alzheimer’s disease	PU